(Q39920364)

15 September 2017

Effect of elongation factor 1alpha promoter and SUMF1 over in vitro expression of N-acetylgalactosamine-6-sulfate sulfatase (English)

1 reference

15 September 2017

Carlos J Alméciga-Díaz

1

0 references

author name string

Maria A Rueda-Paramo

2

1 reference

15 September 2017

Angela J Espejo

3

1 reference

15 September 2017

Olga Y Echeverri

4

1 reference

15 September 2017

Adriana Montaño

5

1 reference

15 September 2017

Shunji Tomatsu

6

1 reference

15 September 2017

Luis A Barrera

7

1 reference

15 September 2017

7 November 2008

1 reference

Molecular Biology Reports

15 September 2017

1 reference

15 September 2017

36

1 reference

15 September 2017

7

1 reference

15 September 2017

1863-1870

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-008-9392-3

15 September 2017

0 references

cites work

Expression, purification and characterization of recombinant human N-acetylgalactosamine-6-sulphatase

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11033-008-9392-3

Preparation of Recombinant Plasmid DNA for DNA-Mediated Gene Transfer.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11033-008-9392-3

Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle

21 January 2018

1 reference

12 December 2020

Modulation of plasmid DNA methylation and expression in zebrafish embryos

1 reference

12 December 2020

Mammalian RNA polymerase II core promoters: insights from genome-wide studies

1 reference

12 December 2020

The RNA polymerase II core promoter: a key component in the regulation of gene expression

1 reference

12 December 2020

Sp1 elements protect a CpG island from de novo methylation

1 reference

12 December 2020

Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice

1 reference

12 December 2020

Enzyme replacement therapy in a murine model of Morquio A syndrome.

1 reference

12 December 2020

The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases

1 reference

12 December 2020

Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs

1 reference

12 December 2020

Coexpression of formylglycine-generating enzyme is essential for synthesis and secretion of functional arylsulfatase A in a mouse model of metachromatic leukodystrophy

1 reference

12 December 2020

Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes

1 reference

12 December 2020

Core promoters: active contributors to combinatorial gene regulation

1 reference

12 December 2020

TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes

1 reference

12 December 2020

Network motifs: theory and experimental approaches

1 reference

12 December 2020

Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapy

1 reference

12 December 2020

SUMF1 enhances sulfatase activities in vivo in five sulfatase deficiencies

1 reference

12 December 2020

Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver.

1 reference

12 December 2020

Widespread correction of lysosomal storage following intrahepatic injection of a recombinant adeno-associated virus in the adult MPS VII mouse

1 reference

12 December 2020

Promoters and control elements: designing expression cassettes for gene therapy.

1 reference

12 December 2020

Construction of strong mammalian promoters by random cis-acting element elongation

1 reference

12 December 2020

Morquio disease: isolation, characterization and expression of full-length cDNA for human N-acetylgalactosamine-6-sulfate sulfatase

1 reference

12 December 2020

Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase.

1 reference

12 December 2020

Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy

1 reference

12 December 2020

Mucopolysaccharidosis IV A: molecular cloning of the human N-acetylgalactosamine-6-sulfatase gene (GALNS) and analysis of the 5'-flanking region

1 reference

12 December 2020

A general binding mechanism for all human sulfatases by the formylglycine-generating enzyme

1 reference

12 December 2020

Gene therapy progress and prospects: transcription regulatory systems.

1 reference

12 December 2020

Long-term enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer

1 reference

12 December 2020

International Morquio A Registry: clinical manifestation and natural course of Morquio A disease.

1 reference

12 December 2020

Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction

1 reference

12 December 2020

Mechanisms of adeno-associated virus genome encapsidation

1 reference

12 December 2020

Gene therapy progress and prospects: gene therapy of lysosomal storage disorders

1 reference

12 December 2020

Mucopolysaccharidoses and the eye.

1 reference

12 December 2020

Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A).

1 reference

12 December 2020

Determinant factors of spectrum of missense variants in mucopolysaccharidosis IVA gene.

1 reference

12 December 2020

The human SUMF1 gene, required for posttranslational sulfatase modification, defines a new gene family which is conserved from pro- to eukaryotes

1 reference

12 December 2020

Gene therapy for lysosomal storage diseases: the lessons and promise of animal models

1 reference

12 December 2020

Development of MPS IVA mouse (Galnstm(hC79S.mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase

1 reference

12 December 2020

Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island

1 reference

12 December 2020

Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres

1 reference

12 December 2020

Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice

1 reference

12 December 2020

Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector

1 reference

12 December 2020

Cell and gene-based therapies for the lysosomal storage diseases

1 reference

12 December 2020

10.1007/S11033-008-9392-3

Identifiers

DOI

1 reference

15 September 2017

1 reference